|
1
|
Edwards BK, Noone AM, Mariotto AB, Simard
EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA,
et al: Annual report to the nation on the status of cancer,
1975–2010, featuring prevalence of comorbidity and impact on
survival among persons with lung, colorectal, breast, or prostate
cancer. Cancer. 120:1290–1314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He J and Chen W: 2012 Chinese cancer
registry annual report. Military Medicine Society Press; Beijing:
2012
|
|
3
|
Pao W and Chmielecki J: Rational,
biologically based treatment of EGFR-mutant non-small-cell lung
cancer. Nat Rev Cancer. 10:760–774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwartz AG, Wenzlaff AS, Bock CH,
Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ,
Harris CC, et al: Admixture mapping of lung cancer in 1812
African-Americans. Carcinogenesis. 32:312–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marshall AL and Christiani DC: Genetic
susceptibility to lung cancer-light at the end of the tunnel?
Carcinogenesis. 34:487–502. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oppermann U: Carbonyl reductases: the
complex relationships of mammalian carbonyl- and quinone-reducing
enzymes and their role in physiology. Annu Rev Pharmacol Toxicol.
47:293–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Forrest GL and Gonzalez B: Carbonyl
reductase. Chem Biol Interact. 129:21–40. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanaka M, Bateman R, Rauh D, Vaisberg E,
Ramachandani S, Zhang C, Hansen KC, Burlingame AL, Trautman JK,
Shokat KM, et al: An unbiased cell morphology-based screen for new,
biologically active small mol-ecules. PLoS Biol. 3:e1282005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tak E, Lee S, Lee J, Rashid MA, Kim YW,
Park JH, Park WS, Shokat KM, Ha J and Kim SS: Human carbonyl
reductase 1 upregulated by hypoxia renders resistance to apoptosis
in hepatocellular carcinoma cells. J Hepatol. 54:328–339. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bains OS, Karkling MJ, Grigliatti TA, Reid
RE and Riggs KW: Two nonsynonymous single nucleotide polymorphisms
of human carbonyl reduct-ase 1 demonstrate reduced in vitro
metabolism of daunorubicin and doxorubicin. Drug Metab Dispos.
37:1107–1114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murakami A, Yakabe K, Yoshidomi K, Sueoka
K, Nawata S, Yokoyama Y, Tsuchida S, Al-Mulla F and Sugino N:
Decreased carbonyl reductase 1 expression promotes malignant
behaviours by induction of epithelialmesenchymal transition and its
clinical significance. Cancer Lett. 323:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Varatharajan S, Abraham A, Zhang W, Shaji
RV, Ahmed R, Abraham A, George B, Srivastava A, Chandy M, Mathews
V, et al: Carbonyl reductase 1 expression influences daunorubicin
metabolism in acute myeloid leukemia. Eur J Clin Pharmacol.
68:1577–1586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang W, Ding L, Huang Q, Hu H, Liu S,
Yang X, Hu X, Dang Y, Shen S, Li J, et al: Carbonyl reductase 1 as
a novel target of (−)-epigallocatechin gallate against
hepatocellular carcinoma. Hepatology. 52:703–714. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schlager JJ and Powis G: Cytosolic NAD
(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor
tissue: Effects of cigarettes moking and alcohol. Int J Cancer.
45:403–409. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gu J, Shen Y and Zhang Y: Association
between interleukin-4 polymorphisms and environment and non small
cell lung cancer in Chinese population. J Cancer Res Ther. 10
Suppl:C135–C139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Hua S, Zhang A, Kong X, Jiang C,
Deng D and Wenlong B: Association between polymorphisms in COMT,
PLCH1 and CYP17A1 and non-small cell lung cancer risk in Chinese
nonsmokers. Clin Lung Cancer. 14:45–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Modesto JL, Hull A, Angstadt AY, Berg A,
Gallagher CJ, Lazarus P and Muscat JE: NNK reduction pathway gene
polymorphisms and risk of lung cancer. Mol Carcinog. 54 Suppl
1:E94–E102. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Waclawik A, Jabbour HN, Blitek A and
Ziecik AJ: Estradiol-17beta, prostaglandin E2 (PGE2) and the PGE2
receptor are involved in PGE2 positive feedback loop in the porcine
endometrium. Endocrinology. 150:3823–3832. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yokoyama Y, Xin B, Shigeto T, Umemoto M,
Kasai-Sakamoto A, Futagami M, Tsuchida S, Al-Mulla F and Mizunuma
H: Clofibric acid, a peroxisome proliferator-activated receptor
alpha ligand, inhibits growth of human ovarian cancer. Mol Cancer
Ther. 6:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jain S, Chakraborty G, Raja R, Kale S and
Kundu GC: Prostaglandin E2 regulates tumor angiogenesis in prostate
cancer. Cancer Res. 68:7750–7759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takenaka K, Ogawa E, Oyanagi H, Wada H and
Tanaka F: Carbonyl reductase expression and its clinical
significance in non-small-cell lung cancer. Cancer Epidemiol
Biomarkers Prev. 14:1972–1975. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Makrilia N, Lappa T, Xyla V, Nikolaidis I
and Syrigos K: The role of angiogenesis in solid tumours: An
overview. Eur J Intern Med. 20:663–671. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kalabus JL, Cheng Q, Jamil RG, Schuetz EG
and Blanco JG: Induction of carbonyl reductase 1 (CBR1) expression
in human lung tissues and lung cancer cells by the cigarette smoke
constituent benzo[a]pyrene. Toxicol Lett. 211:266–273. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
American Cancer Society, . Tobacco and
cancer. http://www.cancer.org/cancer/cancercauses/tobaccocancer/questionsaboutsmokingtobaccoandhealth/Accessed.
October 20–2014.
|
|
25
|
Hockley SL, Arlt VM, Brewer D, Te Poele R,
Workman P, Giddings I and Phillips DH: AHR- and DNA damage-mediated
gene expression responses induced by benzo(a)pyrene in human cell
lines. Chem Res Toxicol. 20:1797–1810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Atalla A, Breyer-Pfaff U and Maser E:
Purification and characterization of oxidoreductases-catalyzing
carbonyl reduction of the tobacco-specific nitrosamine
4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver
cytosol. Xenobiotica. 30:755–769. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Breyer-Pfaff U, Martin HJ, Ernst M and
Maser E: Enantioselectivity of carbonyl reduction of
4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions
from human and rat and by enzymes isolated from human liver. Drug
Metab Dispos. 32:915–922. 2004.PubMed/NCBI
|
